With a $30,000 grant from FRAXA Research Foundation in 1999, Dr. Paul Hagerman and his team at the University of California researched how to re-activate the FMR1 gene and how to measure its levels.
Read moreFMR1 Gene Regulation
Hagerman, Paul
Paul Hagerman, PhD, Investigator at UC Davis MIND Institute, researches the molecular and genetic sources for the fragile X gene, as well as developing targeted treatments for Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome.